Chris Bryant

1.5k total citations
23 papers, 1.0k citations indexed

About

Chris Bryant is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Chris Bryant has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Chris Bryant's work include DNA Repair Mechanisms (3 papers), Signaling Pathways in Disease (3 papers) and Climate Change Communication and Perception (3 papers). Chris Bryant is often cited by papers focused on DNA Repair Mechanisms (3 papers), Signaling Pathways in Disease (3 papers) and Climate Change Communication and Perception (3 papers). Chris Bryant collaborates with scholars based in United Kingdom, United States and Australia. Chris Bryant's co-authors include Andrew J. Massey, Susan M. Stocklmayer, Julia Nguyen, John D. Belcher, Paul R. Bowlin, Gregory M. Vercellotti, John C. Bischof, Robert P. Hebbel, Christopher J. Caunt and Kathleen Conway and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Chris Bryant

23 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Bryant United Kingdom 15 593 227 168 122 116 23 1.0k
Jennifer Brown United States 20 476 0.8× 150 0.7× 93 0.6× 89 0.7× 118 1.0× 57 1.3k
Jonathan H. Sheehan United States 22 975 1.6× 227 1.0× 105 0.6× 75 0.6× 80 0.7× 40 1.6k
Robert Carlson United States 18 683 1.2× 233 1.0× 85 0.5× 55 0.5× 75 0.6× 57 1.2k
Aaron Cooper United States 18 741 1.2× 262 1.2× 147 0.9× 329 2.7× 110 0.9× 31 1.2k
Eva María Galán‐Moya Spain 20 724 1.2× 336 1.5× 134 0.8× 29 0.2× 250 2.2× 60 1.2k
Christian Bach Germany 19 1.2k 2.1× 144 0.6× 79 0.5× 104 0.9× 104 0.9× 82 1.8k
Miguel Gallardo Spain 17 397 0.7× 117 0.5× 136 0.8× 44 0.4× 122 1.1× 54 745
Sylvie Vincent United States 20 1.3k 2.2× 457 2.0× 171 1.0× 118 1.0× 187 1.6× 61 2.1k
Adrian Woolfson United States 15 394 0.7× 185 0.8× 92 0.5× 58 0.5× 32 0.3× 40 959
Scott K. Lyons United States 22 969 1.6× 549 2.4× 91 0.5× 219 1.8× 267 2.3× 47 1.9k

Countries citing papers authored by Chris Bryant

Since Specialization
Citations

This map shows the geographic impact of Chris Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Bryant more than expected).

Fields of papers citing papers by Chris Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Bryant. The network helps show where Chris Bryant may publish in the future.

Co-authorship network of co-authors of Chris Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Bryant. A scholar is included among the top collaborators of Chris Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Bryant. Chris Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herms, Albert, Bartomeu Colom, Gabriel Piedrafita, et al.. (2024). Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus. Nature Genetics. 56(10). 2144–2157. 4 indexed citations
2.
Nichol, Daniel, Joseph Rutter, Chris Bryant, et al.. (2019). Antibiotic collateral sensitivity is contingent on the repeatability of evolution. Nature Communications. 10(1). 334–334. 116 indexed citations
3.
Bryant, Chris, et al.. (2018). The Changing Forms and Values of Architectural Practice. Architectural Design. 88(5). 6–13. 1 indexed citations
4.
Kidger, Andrew M., Linda Rushworth, Chris Bryant, et al.. (2017). Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling. Proceedings of the National Academy of Sciences. 114(3). E317–E326. 67 indexed citations
5.
Conway, Kathleen, Sharon N. Edmiston, Eloise Parrish, et al.. (2017). Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study. Breast Cancer Research and Treatment. 163(2). 349–361. 18 indexed citations
6.
Bryant, Chris, Hongtu Zhu, Mihye Ahn, & Joseph G. Ibrahim. (2017). LCN: a random graph mixture model for community detection in functional brain networks. Statistics and Its Interface. 10(3). 369–378. 3 indexed citations
7.
Conway, Kathleen, Sharon N. Edmiston, Chiu-Kit Tse, et al.. (2015). Racial Variation in Breast Tumor Promoter Methylation in the Carolina Breast Cancer Study. Cancer Epidemiology Biomarkers & Prevention. 24(6). 921–930. 44 indexed citations
8.
Bryant, Chris, et al.. (2015). The Australian Science Centre Movement 1980–2000: Part 1— Questacon , the National Science and Technology Centre. Historical Records of Australian Science. 26(2). 122–132. 2 indexed citations
9.
10.
Rushworth, Linda, Andrew M. Kidger, Laurent Delavaine, et al.. (2014). Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRas Q61L )-driven SerpinB2 expression. Proceedings of the National Academy of Sciences. 111(51). 18267–18272. 65 indexed citations
11.
Fenn, Joe, et al.. (2014). CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited. BMC Cell Biology. 15(1). 6–6. 30 indexed citations
12.
Bryant, Chris, et al.. (2014). Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers. BMC Cancer. 14(1). 570–570. 80 indexed citations
13.
Bryant, Chris, et al.. (2014). Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells. Molecular Cancer. 13(1). 147–147. 43 indexed citations
14.
Conway, Kathleen, Sharon N. Edmiston, Ryan May, et al.. (2014). DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer Research. 16(5). 450–450. 66 indexed citations
15.
Bryant, Chris, S.P. Stokes, & Andrew J. Massey. (2011). Abstract 4458: Chk1 inhibition as a novel therapeutic strategy for treating triple negative breast and ovarian cancers. Cancer Research. 71(8_Supplement). 4458–4458. 3 indexed citations
16.
Potter, Andrew, Christophe Fromont, Stuart Ray, et al.. (2010). Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. Bioorganic & Medicinal Chemistry Letters. 20(22). 6483–6488. 69 indexed citations
17.
Potter, Andrew, Stuart Ray, Chris Bryant, et al.. (2009). Structure-guided design of α-amino acid-derived Pin1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(2). 586–590. 73 indexed citations
18.
Chang, S.-K., et al.. (2008). The Design and Implementation of the Chronobot/Virtual Classroom (CVC) System. 1 indexed citations
19.
Belcher, John D., Chris Bryant, Julia Nguyen, et al.. (2003). Transgenic sickle mice have vascular inflammation. Blood. 101(10). 3953–3959. 181 indexed citations
20.
Bryant, Chris & M. J. H. Smith. (1963). Intermediary Metabolism in HeLa and Human Foetal Liver Cells. British Journal of Cancer. 17(2). 360–364. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Brown Breakdown of academic impact, for papers by Jonathan H. Sheehan Breakdown of academic impact, for papers by Robert Carlson Breakdown of academic impact, for papers by Aaron Cooper Breakdown of academic impact, for papers by Eva María Galán‐Moya Breakdown of academic impact, for papers by Christian Bach Breakdown of academic impact, for papers by Miguel Gallardo Breakdown of academic impact, for papers by Sylvie Vincent Breakdown of academic impact, for papers by Adrian Woolfson Breakdown of academic impact, for papers by Scott K. Lyons
Rankless by CCL
2026